Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Axillary Reverse Mapping (ARM) in Clinically Axillary Node Negative Breast Cancer Patients

NCT04137744 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT04137744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04137744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Axillary Reverse Mapping (ARM) in Clinically Axillary Node Negative Breast Cancer Patients
Lead sponsor
Zagazig University
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2015
Completion date
August 31, 2019
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arm lymphedema, early breast cancer, lymphatic spread of breast cancer